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ABSTRACT
ALCOHOL CONSUMPTION AND MARIJUANA USE INTERACTION WITH METABOLIC SYNDROME
AMONG UNITED STATES ADULTS: ANALYSIS OF NHANES 2013-2014.
By
PIUS AKANDE
APRIL 2018
INTRODUCTION: The relationship between alcohol, marijuana and metabolic syndrome
remains controversial. Marijuana has been found to be a commonly used drug among those
who drink alcohol, yet little is known about the effect of using both substances concurrently
with metabolic syndrome. With decriminalization of marijuana across different states in the
United States, it is expected that the prevalence of marijuana use will increase. Therefore, it is
of utmost importance to understand the adverse impact of these drugs on metabolic
syndrome.
AIM: This study aims to understand (a) the relationship between alcohol and marijuana use and
metabolic syndrome (b) the association between concurrent use of alcohol and marijuana and
metabolic syndrome, and (c) the statistical interaction of alcohol and marijuana use on
metabolic syndrome using the National Health and Nutrition Examination Survey data.
METHODS: A cross-sectional analysis of 2013-2014 National Health and Nutrition Examination
survey data was conducted. Participants aged ≥20 years were eligible. Metabolic syndrome was
defined by the International Diabetes Federation criteria. The adjusted odds ratio of metabolic
syndrome was calculated controlling for variables fitted using stepwise logistic regression
model selection.
RESULTS: After adjusting for age, race, educational level, marital status, poverty, and cigarette
smoking status; current drinkers showed a significant inverse association with metabolic
syndrome (aOR, 0.69 95% CI, 0.49-0.99). The odds of metabolic syndrome in concurrent users
(aOR 0.53 95% CI, 0.28-0.99) was less than the odds among non-concurrent users. Compared
with young adults, middle-aged and older adults had increased odds of metabolic syndrome.
DISCUSSION: This data indicates that alcohol consumption and co-use of alcohol and marijuana
is associated with a lower prevalence of metabolic syndrome. Longitudinal studies are needed
to confirm these findings. Notably, age and smoking are significant predictors of metabolic
syndrome.
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CHAPTER I – INTRODUCTION
1.1. Background
Cardiovascular diseases are the leading cause of death both worldwide and in the
United States.1,2 The risk factors for these diseases tend to aggregate in individuals, and the
collective presence of three or more of these factors has been referred to as Insulin resistance
syndrome or Syndrome X or Metabolic syndrome.
Metabolic syndrome is a disease entity characterized by central obesity, impaired
fasting glucose, raised blood pressure, raised triglycerides and reduced high-density lipoprotein
(HDL) cholesterol.3 It is a heterogeneous cardiovascular risk factor, in that each element of this
syndrome can be a risk factor independently. Research by Stern, William & GonzalezVillalpando (as cited in IDF consensus statement, 2006) concluded that about a quarter of the
world’s adult population has metabolic syndrome.4 Compared to people without the syndrome,
those with metabolic syndrome are twice as likely to die from and thrice more likely to have a
heart attack or stroke.2 Metabolic syndrome poses an indirect economic burden worldwide in
that it increases the risk of Type 2 diabetes by fivefold. The annual direct health care cost
attributed to diabetes worldwide is around 289 billion international dollars (ID), and it is
estimated the cost will increase to over 300 billion ID by 2025. Addressing this problem is
therefore of prime concern. Aside the significant risk factors for metabolic syndrome, other
factors implicated include sedentary lifestyle, use of substances such as cigarette, alcohol, and
marijuana.
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Alcohol consumption and illicit drug use, including marijuana among adults Americans is
a widespread and incessant public health problem with colossal physical, social and economic
consequences for the nation. In 2015, about 13.6 million adults and 22.2 million aged 12 years
and older were current users of marijuana and alcohol respectively.4 The role of alcohol and
marijuana and its effect on metabolic syndrome remain controversial. Studies suggest that
alcohol consumption is related to metabolic syndrome. Light to moderate consumption of
alcohol has been found to inversely related with metabolic syndrome, while heavy
consumption is associated with an increased risk of metabolic syndrome by influencing its
components.5
Marijuana remains a commonly used illicit drug among those who drink.6 The swift
evolution of marijuana policies over the years highlights the need to understand the interaction
of these two drugs and its adverse metabolic outcomes.7 Past research on the association of
marijuana on metabolic syndrome has revealed conflicting results.8,9 Numerous relationships
between independent use of alcohol and marijuana, and risk of metabolic syndrome has been
established, there remains a gap in research about the effect of co-use of both drugs on
metabolic syndrome. Also, there have been very little research on the interaction of alcohol and
marijuana use on metabolic syndrome.

1.2 Research Aims and Hypothesis
This research will determine the extent to which alcohol and marijuana use contributes
to the risk of metabolic syndrome among adults in the United States using data from the
National Health and Nutritional Examination Survey.
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The overall goals will be to explain the independent and interactive association of
alcohol and marijuana use and metabolic syndrome. Also, the relationship between concurrent
use of alcohol and marijuana, and metabolic syndrome will be examined. Gaining more
knowledge about these association will add to the body of literature and assist in public health
planning.
Aim 1: Determine the extent of the relationship between alcohol and marijuana use and
metabolic syndrome.
Hypothesis 1: Independent alcohol and marijuana use, compared to nonuse, will be associated
with metabolic syndrome.
Aim 2: Determine the association between concurrent use of alcohol and marijuana and
metabolic syndrome.
Hypothesis 2: concurrent use, compared to nonuse, will be associated with metabolic syndrome
Aim 3: Determine the statistical interaction of alcohol and marijuana use on metabolic
syndrome.
Hypothesis 3: The effect of Marijuana use on metabolic syndrome is dependent on alcohol use.
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CHAPTER II – Literature Review

2.1. Alcohol and Metabolic Syndrome
According to the World Health Organization, alcohol is a psychoactive substance with
dependent-producing qualities. Harmful use of alcohol is a significant public health concern in
societies because it is implicated in more than 200 disease conditions. Its consumption is
associated health problems such as alcohol dependence, noncommunicable diseases, such as
liver cirrhosis, cardiovascular diseases, and some cancers.10 Alcohol consumption is responsible
for unintentional and intentional injuries, including those that result from violence, suicides,
and road traffic accident.
Globally, about 13.5 grams of pure alcohol per day is consumed by persons aged 15
years or older, and harmful use of alcohol is responsible for 3.3 million deaths every year.
Alcohol consumption is an important long-term risk factor for cardiovascular diseases such as
hypertension, heart disease, and stroke. In the United States, it is responsible for 1 in 10 deaths
among working-age adults aged 20-64 years. In 2010, the economic costs of excessive alcohol
use were nearly $249 billion which translates to $2.05 per day.10
Several studies have focused on the impact of alcohol use on the risk of metabolic
syndrome. Reports are unstable and controversial. Studies have found positive correlations,11
others have found contrary12 or no correlations between alcohol and metabolic syndrome.13
Djousse et al., (2004) in a cross-sectional study involving 4510 white participants of the
National Heart, Lung, and Blood Institute Family Heart Study, examined the association
between total and beverage-specific alcohol consumption and the prevalence odds of
4

Metabolic Syndrome. The authors observed reduced prevalence odds of metabolic syndrome
across all beverage types: compared with never-drinkers, multivariate-adjusted odds ratios
(95% confidence interval) of metabolic syndrome were 0.32 (0.14 to 0.73), 0.42 (0.23 to 0.77),
0.57 (0.30 to 1.09), and 0.56 (0.36 to 0.88) for subjects who consumed >7 drinks/week of wine
only, beer only, spirits only, and more than one type of beverage, respectively. The writers
concluded that irrespective of the type of beverage consumed, alcohol remains associated with
a lower prevalence of Metabolic syndrome.14
Sun et al., (2014) examined the association between alcohol consumption and risk of
metabolic syndrome in a meta-analysis of prospective studies. The authors analyzed data from
six prospective studies involving 28,862 participants with 3305 cases of metabolic syndrome
from different populations (2 studies in Asia, two studies in Europe and 2 in America).
Compared with nondrinkers, very light drinker was associated with decreased risk of metabolic
syndrome [pooled relative risk (RR): 0.86, 95% CL: 0.75-0.99] while heavy drinker was
associated with increased risk of metabolic syndrome (pooled RR 1.84, 95% CI: 1.34-2.52). The
article concluded that heavy alcohol consumption might be associated with an increased risk of
metabolic syndrome. They cautioned, however, the fact that measurement of alcohol
consumption is not standardized could complicate findings among studies. 15
Yokoyama et al., (2007) examined the effect of alcohol consumption on the diagnosis of
metabolic syndrome in a cross-sectional study of 2,130 Japanese men aged 20 to 65 years. The
authors assessed excessive alcohol via questionnaire as people who consume more than 20g
per day, and others were considered as average drinkers. The authors defined metabolic
syndrome with the modified National Cholesterol Education Program: Adult Treatment Panel III
5

(NCEPATPIII) which require the presence of any three of the five components: central obesity,
hypertension, hyperlipidemia, decreased high-density lipoprotein cholesterol, and raised fasting
blood glucose for the diagnosis of metabolic syndrome. Prevalence of metabolic syndrome was
significantly higher in excessive drinkers (22.2%) than average drinkers (13.9%, chi2 = 18.0,
P<0.0001). Yokoyama et al. concluded heavy alcohol consumption might be a factor worsening
metabolic syndrome.11
Santos, Ebrahim & Barros, (2006) conducted a cross-sectional study to determine the
association of physical activity, sleeping hours, alcohol intake and smoking and metabolic
syndromes. The authors examined self-reported social, demographic, personal and family
medical histories and behavioral characteristics of 832 men and 1332 women aged 18—92
years. Alcohol consumption was assessed based on the type of alcoholic beverage and the
amount in grams consumed, and metabolic syndrome was defined using the NCEP/ATP III
criteria. After adjusting for age, education, physical activity, and smoking, there was no
statistically significant relationship between ethanol intake and metabolic syndrome (aOR 1.56,
95% CI, 0.82, 2.96).12
Yokoyama, (2011) in another cross-sectional study involving 371 non-diabetic Japanese
workers examined whether alcoholic beverages could be the remedies for insulin resistance
that plays a pivotal role in the development of Metabolic syndrome. Yokoyama looked at the
correlation between levels of ethanol consumption and insulin resistance. He assessed insulin
resistance by using the homeostatic model assessment (HOMA). Yokoyama found that ethanol
consumption was inversely correlated with insulin resistance levels. He noted, however, that
such beneficial effects may not apply to subjects with obesity. Yokoyama also noted various
6

limitations due to the experimental design, including lack of information on the integrating
amount of ethanol consumption, types of alcoholic beverage and precise evaluation of liver and
pancreatic cirrhosis which can both play a role in insulin resistance.16
(Castelli et al., 1977; Macmahon, 1987 & Langer et al., 1992), revealed (as cited in Frujita
& Takei, 2001) that regular, light to moderate consumption of alcohol could reduce the risk of
coronary heart disease. The authors found that the beneficial effect of light to moderate
alcohol consumption can be explained by several factors, including increases in the high-density
lipoprotein cholesterol, while detrimental impacts of heavy alcohol use are due to an increase
in plasma triacylglycerol and raised blood pressure.4

2.2. Alcohol and Components of Metabolic Syndrome
Several studies have shown that that alcohol consumption has independent effects on
the components of metabolic syndrome. Yoon et al., (2004) examined the relationship between
alcohol and the metabolic syndrome in a secondary analysis of 3597 men and 4365 women who
had participated in the Korean National Health and Nutrition Examination Survey. The adjusted
odds ratio for the metabolic syndrome in the group consuming < 15g of alcohol /day was 0.71
(95% CI: 0.53, 0.95) in men and 0.80 (95% CI: 0.65, 0.98) in women. Also, heavy alcohol
consumption (≥ 30g/d) was associated with significantly higher odds ratios for high blood
pressure and high triacylglycerol in men, and high fasting blood glucose and high triacylglycerol
on women.17
Kim et al., (2017) evaluated the relationship between alcohol consumption and
Metabolic syndrome components in a community-based cohort of 10,037 subjects. The authors
7

found that among men, compared to non-drinker, consumption of >30 g/day showed
significant association with high blood pressure (OR 1.63 95% CI: 1.36-1.94), high fasting
glucose (OR 1.88 95% CI: 1.40-2.51), hypertriglyceridemia (OR 1.77 95% CI: 1.44-2.04) and
inverse association with low HDL cholesterol (OR 0.30 95% CI: 0.25-0.36). The study also found
a similar association between light and moderate drinkers. Among women, the authors found
that heavy drinkers (>30 g/day) are likely to have high fasting glucose (OR 3.50 95% CI: 1.418.71) compared to non-drinkers. The authors concluded that daily alcohol consumption of
>5g/day might contribute to abnormalities of Metabolic syndrome including high glucose and
blood pressure, hypertriglyceridemia, and low HDL cholesterol.18
Most prospective cohorts reviewed revealed that risk of obesity/weight gain, an
essential component of IDF definition metabolic syndrome depends on the amount and type of
alcoholic beverage consumed. Schütze et al., (2009) in a prospective European study, examined
associations between beer consumption and waist circumference (WC). In a secondary analysis
of 7876 men and 12749 women within the European Prospective Investigation into Cancer and
Nutrition (EPIC)-Potsdam study. Men who consumed 1000ml of beer/day had 17% higher WC
compared with light drinkers (≥ 250 to <500ml/day). In women, there was a significant inverse
relationship between beer-abstaining women and WC gain (odds ratio: 0.88 95% CI: 0.81, 0.96)
compared to very-light drinking women. However, after adjusting for concurrent body weight
and hip circumference, a non-significant association was observed.19
Maclnnis et al., (2013) evaluated the predictors of increased adiposity for different
measures of adiposity in a prospective cohort study of 5879 Australian-born participants, aged
40 to 69 years with data collected at baseline (1990—1994) and wave 2 (2003—2007). Subjects
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who consumed low to moderate amounts of alcohol were less likely to have elevated waist
circumference at wave 2. The authors concluded that limiting alcohol intake could be one of the
promising ways of preventing obesity in adults.20
In another prospective study by Rissanen et al., (1991), 12,669 adults were examined
twice with a median interval of 5.7 years. The authors found that heavy drinking was associated
with substantial weight gain in women.21

2.3. Marijuana
Marijuana consists of over 421 components and 60 pharmacologically active
cannabinoids. The two most well-known and understood cannabinoids are delta9tetrahydrocannabinol (THC) and cannabidiol (CBD). Other components are not fully
understood, and their mental and physical effects are unknown.22
Marijuana also known as cannabis act via two receptors; CB1 and CB2. CB1 is mainly
found in the brain and the spinal cord while CB2 receptors are predominately expressed in the
peripheral tissues of cells in the immune system, hematopoietic system, and reticuloendothelial
system. Moreover, acts majorly on the brain and spinal cord.22
Marijuana has many documented toxic effects including acute effects like; impairment
of cognitive and psychomotor function.
Chronic effect of cannabis use includes cannabis dependence syndrome, exacerbation of
symptoms in schizophrenic patients, epithelial injury of the respiratory system, and increased
prevalence of chronic bronchitis.23
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2.4 Marijuana Prevalence
According to the Center for Disease Control (CDC), marijuana is the most commonly
used illegal drug in the united states with about 22.2 million users every month, 3 and it has a
very high index for addiction. Research shows that 1 in every ten marijuana users will become
addicted.24 Worldwide, it is the most used illicit drug, about 2.5% of the world population
consume cannabis which is higher than 0.2% consuming cocaine and 0.2% consuming opiates. 22
With the decriminalization and legalization of marijuana, the significant public health
concern is that its legalization will increase its use. Currently, 23 states and territories in the
USA have legalized medical marijuana use, and recreational use is now legal in four states.25
2.5. Marijuana and Metabolic Syndrome
Evidence from studies suggests that marijuana use influences the cardiovascular
physiology. It increases heart, systolic and diastolic blood pressures; these actions increase the
oxygen demand of the myocardium.7
The risk of cardiovascular disease increases by about five times for users and more for
users with pre-existing conditions.26 Metabolic syndrome is a well-known major risk factor for
cardiovascular diseases; therefore, it is relevant to review marijuana’s effect on the syndrome.
Franz & Frishman 2016, evaluated recreational marijuana and cardiovascular disease,
the authors found that smoking marijuana increases the risk of myocardial infarction by a factor
of 4.8 for the 60 minutes after marijuana use. Franz and Frishman recommended against the
recreational marijuana use, especially in individuals with a history of coronary artery diseases. 7
Vidot et al., (2015) used data from a representative study of US adults aged 20- to 59years, the National Health and Nutrition Examination Survey (NHANES), to explore the
10

relationship between marijuana use and metabolic syndrome. The investigators found that
current marijuana users had lower odds of metabolic syndrome than never users (adjusted
odds ratio [AOR] 0.69; 95%confidence intervals [CI], 0.47-1.00; P =. 05). Besides, among
emerging adults (20-30 years old), current marijuana users were 54% less likely than never
users to present with metabolic syndrome. Compared with never users, past (AOR 0.61; 95% CI,
0.40-0.91) and current (AOR 0.49; 95% CI, 0.25-0.97) middle -age marijuana users were less
likely to develop metabolic syndrome.27
Thompson and Hay, (2015) in a cross-sectional study examined the relationship of
metabolic risk factors and marijuana use in U.S. adults using the data from the continuous
National Health and Nutrition Examination Survey (NHANES). Using the data on from 6281
participants and computing the ordinary least squares (OLS) models, revealed that fasting
insulin, insulin resistance, body mass index, and waist circumference were all significantly lower
in current marijuana users compared to lifetime non-users. To test the reliability of the model,
the researchers substituted marijuana use with alcohol use as the risk factor of interest; the
result was like the estimates of the effect of marijuana use. The authors concluded that while
current users of marijuana may less likely develop metabolic syndrome, OLS regression might
not be a reliable model to examine the association.8
Muniyappa et al., (2013) also examined the metabolic effect of chronic cannabis
smoking. In the cross-sectional case-control study, 18 men and 12 women aged 27 ± 8 years
were matched for sex, age, body mass index and ethnicity with 30 controls. The authors found
that chronic cannabis smoking was associated with visceral adiposity (18 ± 9 vs. 12 ± 5%;
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p=0.004). lower HDL cholesterol (49 ± 14 vs. 55 ± 13 mg/dL; p= 0.02), and adipose tissue insulin
resistance,28 all components of metabolic syndrome.
Le Strat and Le Foll, (2011) analyzed data from 2 cross-sectional epidemiologic studies of
US adults aged 18 years or older, the National Epidemiologic Survey on Alcohol and Related
Conditions (NESARC; 2001–2002) and the National Comorbidity Survey–Replication (NCS-R;
2001–2003). The specific aim was to estimate the prevalence of obesity as a function of
cannabis use. The authors found that adjusted prevalence of obesity in the NESARC and the
NCS-R were 22.0% and 25.3%, respectively among subject reporting no use of cannabis in the
past 12 months and 14.3% and 17.2%, respectively, among participants reporting the use of
cannabis at least three days per week. Additionally, after adjusting for sex and age, the use of
cannabis was associated with body mass index differences in both samples. The authors
concluded that the prevalence of obesity is lower in cannabis users than in nonusers.29
In a recent study, Yankey et al., (2017) evaluated the relationship between years of selfreported marijuana use and metabolic syndrome using the National Health and Nutrition
Examination Survey (NHANES) 2011-2012. Surprisingly, irrespective of the criteria used, the
adjusted odds ratio (aOR) for having metabolic syndrome with each increase in year of
marijuana use. The aOR was 1.05 (95% CI: 1.02, 1.08), 1.08 (95% CI: 1.04, 1.13) and 1.05 (95%
CI: 1.04, 1.13) for National Cholesterol Education Program Adult Treatment Panel III (ATP III),
International Diabetes Federation (IDF), and World Health Organization (WHO) respectively.
Furthermore, the authors found a significant association between each year of marijuana use
and components of metabolic syndrome (hypertension and abdominal obesity). The adjusted
OR of Hypertension was 1.05 (95% CI: 1.01, 1.09) for WHO criteria and 1.08 (95% CI: 1.03, 1.12)
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using EGIR. Irrespective of the criteria, each year of marijuana use was associated with
increased odds for abdominal obesity: aOR 1.06 (95% CI: 1.00, 1.11) (ATP III), 1.09 (95% CI: 1.05,
1.14) (EGIR), and 1.07 (95% CI: 1.01, 1.13) (IDF). The authors concluded that recreational
marijuana use might be detrimental to cardiovascular health.30

2.6.

Alcohol and Marijuana co-use and Metabolic Syndrome.
The decriminalization and legalization of marijuana coupled with the consumption of

alcohol in significant amounts raise a public health concern. Pacula and Sevigny, (2014) argued
that marijuana liberalization policies could lead to increases in both alcohol and marijuana use,
hence the need to fully understand the association between these two substances, especially
about their public health consequences.31
Subbaraman & Kerr, (2015) examined the differences in demographics, alcohol-related
social consequences, harms to self, and drunk driving across simultaneous, concurrent and
alcohol-only groups. The authors conducted a secondary analysis of data from the 2005 and
2010 National Alcohol Survey involving 4,522 females, and 4,104 males. The authors found that
individuals who used both cannabis and alcohol tend to use them at the same time
(simultaneous use). Also, compared with alcohol only use, the odds of drunk driving, social
consequences, and harms to self is two times among simultaneous users.5
Alcohol consumption and marijuana use have independently been associated with
metabolic syndrome. However, little or no study has examined the combined effects of alcohol
consumption and marijuana use on metabolic syndrome. Findings from the literature reviewed
suggest that interaction of these drugs may result in detrimental effect. This thesis will also
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examine the interaction of alcohol consumption and marijuana use on metabolic syndrome.
Understanding the interaction between alcohol and marijuana and the risk of metabolic
syndrome will add to the body of knowledge, assist in policy initiatives and the implementation
of effective preventive strategies against cardiovascular diseases.

14

CHAPTER III – METHODOLOGY

3.1. Study Design
This research will analyze data from the National Health and Nutrition Examination
Survey (NHANES). NHANES is a scheme of studies that assess the health and nutritional status
of adults and children in the United States. It is under the oversight of National Center for
Health Statistics (NCHS), a division in the Centers for Disease Control and Prevention with the
responsibility of producing vital and health statistics for the country.
The program started over five decades ago, and it is an ongoing revolving survey that
addresses the health and nutritional topics of different populations. The survey examines about
5,000 nationally representative sample annually, located in various counties across the nation,
fifteen of which are visited.
The survey has two components; Using Computer-Assisted Personal Interview
Technology (CAPI), for conducting an initial in-person interview in the participant’s home, and it
includes; demographic, socioeconomic, dietary health-related questions. The examination
component which consists of medical, dental, physiological measurements, and laboratory tests
conducted by highly trained medical personnel in specifically designed mobile examination
centers (MEC). This survey collects information on prevalence of chronic conditions in the
population. Also, it provides an estimate of previously undiagnosed conditions as well as
aspects of a person’s lifestyle, heredity, constitution, or environment that may increase the
chances of developing a specific disease
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Data of this survey are used in epidemiological studies and health sciences research,
which help build effective public health initiative and policy. Also, information from the survey
helps the public health professionals determine disease prevalence and predisposing factors,
assess nutritional status and its association to health promotion and prevention.
Eligibility criteria: adults ≥ 20 years who were involved in the 2012-2013 NHANES were
included in the study.
Variables of Interest
Dependent Variable
Metabolic Syndrome
Metabolic Syndrome was defined using the International Diabetes Federation (IDF)
criteria. These criteria were used because central obesity which is the driver for most
cardiovascular diseases was used as the primary criterion. It is also a universally accessible,
diagnostic tool that addresses both clinical and research needs by providing a comprehensive
list of criteria including ethnic specific cut-off points that should be included in research into the
metabolic syndrome.
IDF defined Metabolic Syndrome as the presence of:
Central Obesity: defined as waist circumference with ethnicity-specific values; ≥ 102 cm
(white males) or ≥ 88 cm (white females); ≥ 94 cm (black males) or ≥ 80 cm (black females); ≥
94cm (Mexican American/Multiracial males) or ≥ 80 cm (Mexican American/Multiracial
females). The IDF recommends ethnic group-specific cut-points should be used for people of
the same ethnic group wherever they are found. Thus, the criteria recommended for central
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Americans was also be used in Mexican Americans, as would those for central Americans males
and females regardless of place and country of residence.
Plus any two of the following: raised triglycerides ≥ 150mg/dL or on treatment for this
lipid abnormality; reduced HDL cholesterol <40 mg/dL in males and < 50mg/dL in females or on
treatment for this lipid abnormality; raised blood pressure systolic blood pressure ≥ 130 or
diastolic blood pressure ≥ 85 mm Hg or on treatment for previously diagnosed hypertension;
raised fasting plasma glucose (FPG) ≥ 100mg/dL, or previously diagnosed type 2 diabetes.
Information about laboratory and clinical procedures are well-documented in the
NHANES manual.32
Independent Variables
Main independent variables were marijuana and alcohol use.
Marijuana Use
Marijuana use was categorized into current marijuana users (those who have used
marijuana before and at least ≥ one day in the last 30days), and never marijuana users (never
used marijuana). The definition was based on the following questions: 1.) Ever used marijuana
or hashish? 2.) During the past 30 days, on how many days did you use marijuana or hashish?
Alcohol Use
Alcohol use was categorized into nondrinkers (have not had any drink in the past 12
months and not up to 12 drinks in their entire lifetime), current drinkers (had at least 12 drinks
in the past year and had a drink at least ≥ one day in the last 30 days). According to the National
Institute on Alcohol Abuse and Alcoholism, current drinkers were further divided into
low/moderate drinkers (men: up to 2 drinks per day, women: up to a drink per day), and heavy
17

drinker (men: 4 or more drinks on any day, women: 3 or more drinks on any day). 33 Alcohol use
definition was based on the following questions; 1.) In your entire life, have you had at least 12
drinks of any alcoholic beverage? 2.) In any one year, have you had at least 12 drinks of any
type of alcoholic beverage. 3.) In the past 12 months, on those days that you drank alcoholic
beverages, on the average, how many drinks did you have? 4.) How many days per week, per
month, or per year did you drink alcohol?

Concurrent Use
Based on the current drinking and marijuana status, a new indicator variable addressing
concurrent use was created. Concurrent users were categorized as Yes: (if classified as both
current drinker and current marijuana user) and No (classified as either a current drinker or
current marijuana user).
Other Independent Variables
Age
Reported as the age in years at the time of participation. Participants were evenly
distributed across three age categories young adults (20-35) years, middle-aged adults (36-55)
years and older aged adults (> 55) years
Race
Categorized into White, African American, Hispanics, and Other Race/Multi-racial
Gender
Gender of the participant at the time of screening. Grouped into male and female based
on self-reported data.
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Educational level
Categorized into ≤ High School and > High school.
Family to income ratio (PIR)
PIR denotes the ratio of the family’s income to the poverty threshold. PIR was used in
this study as a measure of socioeconomic status. Based on the standard recommended by
United States Poverty Guideline 2018, participants’ PIR was classified into three categories; <
1.00, 1.00 - 4.00, and > 4.00.
Marital status
For this study, participant’s marital status is categorized as Married and Others.
Physical Activity
Physical activity was categorized into two groups: physically active and physically
inactive. Participants were allocated to this group based on their response to the following
questions from the NHANES questionnaire: “In a typical week do you do any vigorous-intensity
sports, fitness, or recreational activities that cause large increases in breathing or heart rate like
running or basketball for at least 10 minutes continuously?” or “ In a typical week do you do
any moderate-intensity sports, fitness, or recreational activities that cause a small increase in
breathing or heart rate such as brisk walking, bicycling, swimming, or volleyball for at least 10
minutes continuously?” participants that responded ‘yes’ to either of the aforementioned
questions were classified as physically active while those that responded ‘no’ were allocated to
the physically inactive group.
Cigarette Smoking
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Current cigarettes smokers: Participants who reported they had smoked at least 100
cigarettes in their lifetime, and still smoke on some days or every day. Past smokers:
participants who have smoked at least 100 cigarettes in their lifetime but do not currently
smoke. Never smoker: those who have never smoked cigarettes.

3.2. Statistical Analysis
All analyses were performed using SAS 9.4 (Statistical Analysis System, Cary, NC, USA). In
2013-2014, NHANES included 14,332 persons selected from 30 different survey locations to
participate in the study. Of those selected, 10,175 and 9,813 completed the interview and
examination respectively. For this thesis, the sample size was 2,142 (20 years and older).
Descriptive statistics were conducted for all participant characteristics including age,
gender, race, marital status, education, and family to income ratio (PIR). Bivariate analyses
were conducted using Chi-Square Test for categorical variables and the Wilcoxon Rank sum test
for continuous variables.
Multivariable logistic regression models were constructed to explore the effects of the
primary independent variables on metabolic syndrome. The logistic regression results are
reported as odd ratios (OR) and 95% confidence interval (CI). A Stepwise selection method was
used to identify the significant predictors of metabolic syndrome. A significance level of 0.3 is
required to allow a variable into the model (SLENTRY= 0.3), while a significance level of 0.35 is
required for a variable to stay in the model (SLSTAY= 0.35). The final model included variables
fitted by stepwise selection and a priori, potential confounders identified by the bivariate
analysis. Overall, three models were fitted – alcohol consumption, marijuana use, & concurrent
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use. The statistical interaction between alcohol consumption and marijuana use was also
assessed using their product term, with the level of significance determined using the likelihood
ratio test. A two-sided P value < 0.05 was considered statistically significant for all analyses.
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CHAPTER IV – RESULTS
4.1.

Descriptive Statistics
Overall, 2,239 participants aged 20 years and older were included in this analysis. The

demographic and other characteristics of participants who self-reported for alcohol and
marijuana use were similar. Participants with missing data on the variable of interest were
excluded. Most respondents were between 35 and 55 years, and nearly half of the participants
who self-reported for alcohol and marijuana were whites (34%-41.6%). Majority attained above
high school education (59% – 62.6%), are physically inactive (62% – 63.2%) and met the IDF
definition for central obesity (67%).
Alcohol Use Characteristics
Of the participants, 930 (77.2%) were current drinkers, and 275 (22%) were nondrinkers. 55.5% are males, and 45.5 % are females. Current drinkers are mostly young adults
(37.9%) and middle-aged adults (41.6%). White Americans consume alcohol at the highest rate
among major ethnic groups (45.4%), followed by blacks (21.6%), Hispanics (20.4%), and other
races (12.6%). Almost have of current drinkers had above high school education (65.0%), are
physically inactive (60.9%) and are current smokers (26.8%). (Table 1.1).
The Proportion of Central obesity among current drinkers was 57.8% compared to
70.8% among non-drinkers (P < 0.01). Prevalence of raised fasting blood glucose, raised systolic
blood pressure, and low HDL cholesterol was similar in the participants who were current and
non-drinkers.
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Marijuana Use Characteristics
There were 223(23.8%) current users and 714(76.2%) never users of marijuana. Majority of
current users are young (64.6%). Marijuana use was highest among whites (46.6%), followed by
blacks (29.6%), Hispanics (14.8%) and other races (9%). Males are nearly twice as likely (62.8%)
to use marijuana as females (37.2%). Current marijuana use is also more common among
participants who are not legally married (78%), had above high school education (52%),
physically inactive (51.1%) and current smokers (56.5%).
Participants who reported current use of marijuana have significantly lower body waist
circumference (median 89.6 vs 95.5 cm, P = < 0.01), fasting plasma glucose (median 95.0 vs 97
mg/dl, P = < 0.01), and diastolic blood pressure (median 68 vs 72 mmHg, P = <0.01) compared
to those who never smoked marijuana.
Metabolic Syndrome
Metabolic syndrome prevalence among participants using International Diabetes
Federation (IDF) criteria was 29.2%. A Majority were 36 years and older. Prevalence of
metabolic syndrome was 24.1%, 17.7%, and 13.6%, among current drinkers, current marijuana
users, and concurrent users respectively.

4.2.

Result of Bivariate Analysis
Alcohol and Participant’s characteristics
Results revealed a statistically significant difference between alcohol and each of the

participant’s characteristics (age, gender, race, education, family to income ratio, physical
activity, smoking- P < 0.01 for all). There was a statistically significant difference between
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alcohol use and body waist circumference (P < 0.01), HDL cholesterol (P < 0.01). There was no
significant difference observed between alcohol use and fasting plasma glucose, triglyceride
level, systolic and diastolic blood pressure (Table 1.1).
Marijuana and Participant’s characteristics (Table 1.2)
Furthermore, a statistically significant difference was observed between marijuana use
and each of the following participant’s characteristics (age, gender, race, marital status, family
to income ratio, physical activity, education and cigarette smoking- P < 0.01 for all). A similar
result was found between marijuana use and some components of metabolic (body waist
circumference [P < 0.01] and fasting plasma glucose [P < 0.01]).
Metabolic Syndrome and Participant’s characteristics (Table 1.3)
The Chi-square test of association between metabolic syndrome and each of the
participant’s characteristics (age group, race, education, marital status, family to income ratio,
and cigarette smoking- P < 0.01 for all) found a statistically significant difference between the
variables. There was a statistically significant difference between metabolic syndrome and each
of the two primary independent variables (alcohol and marijuana use, P = 0.02).
4.3.

Result of Multivariate Analysis
In the unadjusted analysis, current drinkers were less likely to have metabolic syndrome

compared to non-drinkers (odds ratio [OR], 0.69 95% confidence interval [CI], 0.51-0.94). The
analysis also revealed similar associations for both current marijuana users and concurrent
users, with OR, 0.59 95% CI, 0.40-0.86 and OR, 0.44 95% CI, 0.26-0.73 respectively. The odds of
metabolic syndrome were lower participants that consume low/moderate alcohol compared to
non-drinkers OR, 0.70 95% CI, 0.49, 0.99 (Table 3.1).
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Table 2.1, 2.2, and 2.3 give a summary of the stepwise logistic regression model
selection. After adjusting for age, race, educational level, marital status, poverty, and cigarette
smoking status; current drinkers showed a significant inverse association with metabolic
syndrome (adjusted odds ratio [aOR], 0.69 95% confidence interval [CI], 0.49-0.99). In the same
multivariable model, compared with participants aged 20-35 years, adults between 36 and 55
years (aOR, 2.57 95% CI, 1.80-3.68) and above 55 years (aOR, 3.36 95% CI, 2.26-4.99) had higher
odds of metabolic syndrome. Participants who are past smokers had more odds developing
metabolic syndrome compared to non-smokers. The odds of metabolic syndrome among
current marijuana users was lower compared to never users, although this association was not
significant (aOR, 0.62 95% CI,0.38, 1.01).
Similarly, the odds of Metabolic syndrome among concurrent users was 0.53 times the
odds of metabolic syndrome among non-concurrent users (95% CI, 0.28-0.99). In both
marijuana and concurrent model, being 36 years and older was significantly associated with
increased odds of metabolic syndrome (Table 3.2). Test for statistical interaction between
alcohol consumption and marijuana use revealed no statistically significant result, and thus the
product term was not included in the model.
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CHAPTER V – Discussion
5.1.

Discussion
The purpose of this thesis was to evaluate alcohol and marijuana use interaction on

metabolic syndrome among United States adults. Marijuana remains a commonly used illicit
drug among those who drink, coupled with the swift evolution of marijuana policies over the
years, there a need to understand the interaction of these two drugs and its adverse metabolic
outcomes.
This study was conducted by using NHANES data, a survey that examines the nationally
representative sample of about 5,000 persons per year. The survey collects data on the
prevalence of chronic conditions in the population as well as information on aspects of a
person’s lifestyle, heredity, constitution, or environment that may increase the chances of
developing a specific disease. The survey also employed the use of Computer-Assisted Personal
Interview Technology (CAPI), this allows for clarification and ascertainment of responses.
Overall, results from this study suggest that current drinkers, current marijuana users,
and concurrent users were associated with decreased odds of metabolic syndrome. Adjusting
for age group, race, educational level, marital status, cigarette smoking, and family to income
ratio; the negative association remained significant with a notable exception for current
marijuana users. The analysis also found that among current drinkers, those who consumed low
to moderate proportion of alcohol have lower odds of metabolic syndrome. Participants who
were 36 years and above were consistently associated with increased odds of metabolic
syndrome in all three models.
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Most researchers have focused on the independent relationship of alcohol and
marijuana use on metabolic syndrome. This thesis is probably the first study till date to examine
the association between concurrent alcohol/marijuana use and its effect on metabolic
syndrome. Although, this analysis observed an inverse association between concurrent use and
metabolic syndrome (aOR, 0.53 95%, 0.28-0.99), still, cautious interpretation of this result is
needed. This observed association could be because of how concurrent use was assessed. It is
important to note that, questions relating to the concurrent use of alcohol and marijuana were
not directly asked in the NHANES data, and therefore the assessment of concurrent use could
be biased. It is imperative to conduct further longitudinal studies to confirm if the observed
association is indeed true.
The observed inverse association between alcohol use and metabolic syndrome is
similar to findings from previous studies. Djousse et al., (2004) cross-sectional survey of
participants of the National Heart, Lung, and Blood Institute Family Heart Study reported
reduced prevalence odds of metabolic syndrome among alcohol users across all beverage
types: OR, 95% -- 0.32 (0.14 to 0.73), 0.42 (0.23 to 0.77), 0.57 (0.30 to 1.09), and 0.56 (0.36 to
0.88) for subjects who consumed more than 7 drinks/week of wine only, beer only, spirits only,
and more than one type of beverage, respectively.14 The result of this study is not comparable
to this present study because the authors computed beverage-specific alcohol concentrations,
and the reported association was not consistent across all beverage groups.
This thesis also found that low/moderate intake of alcohol is associated with lower odds
of metabolic syndrome. Earlier studies have also reported similar association. A prior metaanalysis of six prospective studies in 2014 including 28,862 participants found that very light
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drinkers have a decreased risk of metabolic syndrome (Pooled RR: 0.86, 95% CL: 0.75-0.99).15
The research was more superior because the authors conducted a meta-analysis of prospective
studies with no evidence of heterogenicity or publication bias between the very light and heavy
alcohol groups. However, non-standardized methods for assessing alcohol consumption noted
in the study could complicate interpretation of findings among studies. On the other hand,
people that consume alcohol in low to moderate proportion usually opt for wine instead of
beer and spirit. It is plausible to say that the observed inverse association may be due to other
substances found in wine rather than the ethanol itself.
Also, studies have also found conflicting results on whether alcohol use has a protective
or detrimental effect on metabolic syndrome. Alcohol has a variable effect on components of
metabolic syndrome. Freiberg et al., (2003) in a cross-sectional analysis on data from 8,125
participants from the Third National Health and Nutrition Examination Survey reported that
alcohol use was significantly and inversely associated with the prevalence of the following three
components of the metabolic syndrome: low serum HDL cholesterol, elevated serum
triglycerides, high waist circumference, as well as hyperinsulinemia (P < 0.05 for all). Thus, the
inverse relationship observed may differ based on the metabolic profile of the group being
studied.
Notably, in all the models constructed, being 36 years and older have higher odds of
metabolic syndrome, and this was consistent with previous studies that reported that
prevalence of metabolic syndrome increases with age. 34 A previous cross-sectional survey in
2012 reported age might influence the relationship between alcohol and metabolic syndrome.35
In all the models constructed for this study, compared to young adults aged 20-35 years,
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participants between 36-55 years are over two times likely to have metabolic syndrome and
those >55 years are over three times more likely to develop the syndrome. It will be imperative
to understand age-specific relationship between alcohol, marijuana, and metabolic syndrome.
Another finding from this research indicates that past smokers have higher odds of
metabolic syndrome. A similar association was observed in previous studies.36 A 2015 study
reported that former smokers had a higher risk of metabolic syndrome compared to light
smokers (pooled RR 1.19, 95% CI: 1.00–1.42).37 These findings could be because smoking is
strongly associated with obesity, a significant determinant in the IDF definition used for this
study, and higher odds of metabolic syndrome further support the hypothesis that smoking has
a peripheral metabolic effect in the body. Smokers are likely to have reduced calorific intake,
which translates to less absorption and storage of fats in adipose tissues. The cessation of
smoking reverses this process.37
5.2.

Study Limitations and next steps
Despite apparent strength of using a nationally representative survey for this analysis,

this study is subject to limitations. Firstly, the NHANES is cross-sectional; no casual inferences
can be made from these data. This design cannot establish temporality because information
about whether the alcohol or marijuana use preceded the development of metabolic syndrome
is not available. The possibility of reverse causality bias cannot be ruled out. More detailed
longitudinal studies are required to confirm these findings. Secondly, alcohol and marijuana use
were also accessed via self-report data which are subject to reporting bias. There’s no way to
ensure that respondents gave accurate answers to questions or just gave a socially desirable
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response. Biochemical verification may be necessary for objective assessment of these
responses.
5.3.

Conclusion
The result of this study suggests that there an inverse relationship between alcohol,

concurrent alcohol & marijuana use, and metabolic syndrome. However, interpretation should
be made with caution. With the evolving climate of decriminalization of marijuana and limited
research on its potential health effects, policymakers, especially at the state level should
understand this lack of knowledge is a notable barrier not only to scientific understanding but
also to the improvement of public policy and public health of the populace.
The public should be made aware of the role of increasing age and smoking as
important predictors of metabolic syndrome and the need to institute lifestyle modifications in
high-risk groups.
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Table 1.1 Participants Characteristics stratified by Alcohol Use

Demographics
Age
Median (IQR)
20-35
36-55
>55
Gender
Female
Male

Alcohol Use
Current Drinker
Non-Drinker
N (%) = 930 (77.2)
N (%) = 275 (22.8)

Total

P-value
-

1205

41.0 (29.0-53.0)
352 (37.9)
387 (41.6)
191 (20.5)

47.0 (32.0-58.0)
81 (29.5)
102 (37.1)
92 (33.4)

45.0 (33.0-57.0)
433 (35.9)
489 (40.6)
283 (23.5)

414 (44.5)
516 (55.5)

197 (71.6)
78 (28.4)

611 (50.7)
594 (49.3)

<0.01 w
<0.01c

<0.01c

Race
Hispanic
190 (20.4)
70 (25.5)
White
422 (45.4)
76 (27.6)
African- American
201 (21.6)
54 (19.6)
Other Race/Multi-racial
117 (12.6)
75 (27.3)
Education
≤ High School
325 (35.0)
125 (45.6)
> High School
604 (65.0)
149 (54.4)
Marital Status
Married
468 (50.3)
159 (57.8)
Others
462 (49.7)
116 (42.2)
Poverty to Income Ratio
Median (IQR)
2.7 (1.2-4.9)
1.64 (0.9-3.3)
<1.00
219 (23.6)
100 (36.4)
≥1.00-4.00
399 (42.9)
135 (49.1)
>4.00
312 (33.5)
40 (14.6)
Physical Activity
Active
364 (39.1)
79 (28.7)
Inactive
566 (60.9)
196 (71.3)
Cigarette Use
Current Smoker
249 (26.8)
19 (6.9)
Past Smoker
199 (21.4)
16 (5.8)
Non-smoker
482 (51.8)
240 (87.3)
Clinical Information
Body waist circumference, cm
Median (IQR)
97.0 (91.0-105.0)
95.5 (84.4-108.0)
Central Obesity
530 (57.8)
187 (70.8)
Normal
387 (42.2)
77 (29.2)
Fasting plasma glucose, mg/dl
Median (IQR)
95.2 (84.8-106.6)
99.0 (91.0-107.0)
< 100
523 (58.0)
148 (55.4)
≥ 100
379 (42.0)
119 (44.6)
Blood Pressure, mmHg,
Systolic blood pressure
Median (IQR)
118.0 (108-128)
118.0 (108-130)
< 130
666 (76.6)
186 (73.5)
≥ 130
203 (23.4)
67 (26.5)
Diastolic blood pressure
Median (IQR)
70.0 (64.0-76.0)
70.0 (64-78.0)
< 85
785 (90.3)
232 (91.7)
≥ 85
84 (9.7)
21 (8.3)
HDL Cholesterol, mg/dl
Median (IQR)
53.0 (43.0-63.0)
52.0 (43.0-64.0)
Low
219 (24.4)
91 (34.3)
Normal
679 (75.6)
174 (65.7)
Triglyceride, mg/dl
Median (IQR)
89.0 (62.0-136.0)
94.0 (67.0-138.0)
High
203 (22.6)
59 (22.3)
Normal
695 (77.4)
206 (77.7)
Abbreviations: IQR, interquartile range; ARV, antiretroviral.
c Chi-square statistical test was used to test for association
w Wilcoxon rank sum test was used to test for median difference
*P-value highlighted in bold indicate the finding is statistically significant at α=0.05 (p< .05)
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<0.01c
260 (21.6)
498 (41.3)
255 (21.2)
192 (15.9)
<0.01c
450 (37.4)
753 (62.6)
0.03c
627 (52.0)
578 (48.0)
2.1 (1.0-4.2)
319 (26.5)
534 (44.3)
352 (29.2)

<0.01 w
<0.01 C

<0.01c
443 (36.8)
762 (63.2)
<0.01c
268 (22.2)
215 (17.8)
722 (59.9)

97.0 (86.0-108.0)
717 (60.7)
464 (39.3)

0.21
<0.01c

98.0 (92.0-108.0)
671 (57.4)
498 (42.6)

0.20w
0.46c

118.0 (108-128)
852 (75.9)
270 (24.1)

0.53w
0.31c

70.0 (64.0-78.0)
1017 (90.6)
105 (9.4)

0.63w
0.51c

51.0 (42.0-62.0)
310 (26.7)
853 (73.3)

0.87w
<0.01c

94.0 (64.0-143.0)
262 (22.5)
901 (77.5)

0.23w
0.91c

Table 1.2 Participants Characteristics stratified by Marijuana Use

Demographics
Age
Median (IQR)
20-35
36-55
>55
Gender
Female
Male
Race
Hispanic
White
African- American
Other Race/Multi-racial
Education
≤ High School
> High School
Marital Status
Married
Others
Poverty to Income Ratio
Median (IQR)
<1.00
≥1.00-4.00
>4.00
Physical Activity
Active
Inactive
Cigarette Use
Current Smoker
Past Smoker
Non-smoker
Clinical Information
Body waist circumference, cm
Median (IQR)
Central Obesity
Normal
Fasting plasma glucose, mg/dl
Median (IQR)
< 100
≥ 100

Marijuana Use
Current User
Never User
N (%) = 223 (23.8)
N (%) = 714 (76.2)

Total

P-value
-

937

30.0 (24.0-43.0)
144 (64.6)
72 (32.3)
7 (3.1)

41.5 (31.0-50.0)
237 (33.2)
406 (56.9)
71 (9.9)

45.0 (33.0-57.0)
381 (40.7)
478 (51.0)
78 (8.3)

83 (37.2)
140 (62.8)

427 (59.8)
287 (40.2)

868 (48.6)
919 (51.4)

<0.01w
<0.01c

<0.01c

<0.01c
33 (14.8)
104 (46.6)
66 (29.6)
20 (9.0)

232 (32.5)
218 (30.5)
110 (15.4)
154 (21.6)

265 (28.3)
322 (34.4)
176 (18.8)
174 (18.6)

107 (48.0)
116 (52.0)

277 (38.8)
437 (61.2)

384 (41.0)
553 (59.0)

49 (22.0)
174 (78.0)

440 (61.6)
274 (38.4)

489 (52.2)
448 (47.8)

1.3 (0.69-2.8)
93 (41.7)
97 (43.5)
33 (14.8)

2.3 (1.0-4.3)
211 (29.6)
322 (45.0)
181 (25.4)

2.1 (1.1-4.2)
304 (32.4)
419 (44.8)
214 (22.8)

109 (48.9)
114 (51.1)

240 (33.6)
474 (66.4)

349 (37.2)
588 (62.8)

126 (56.5)
25 (11.2)
72 (32.3)

72 (10.1)
69 (9.7)
573 (80.3)

198 (21.2)
94 (10.0)
645 (68.8)

89.6 (80.7-101.3)
98 (44.6)
122 (55.4)

95.5 (84.4-108.0)
470 (67.1)
230 (32.9)

95.6 (85.2-107.1)
568 (61.7)
352 (38.3)

<0.01w

95.0 (89.0-101.0)
151 (70.6)
63 (29.4)

97.0 (92.0-105)
408 (58.5)
289 (41.5)

98.0 (92.0-108.0)
559 (61.4)
352 (38.6)

<0.01w
<0.01c

116.0 (108.0-127.0)
173 (81.6)
39 (18.4)

116.0 (108.0-126)
540 (81.2)
125 (18.8)

118.0 (108-128)
713 (81.3)
164 (18.7)

0.78w
0.89c

68.0 (60.0-74.0)
194 (91.5)
18 (8.5)

72.0 (64-78.0)
599 (90.1)
66 (9.9)

70.0 (64.0-78.0)
793 (90.4)
84 (9.6)

HDL Cholesterol, mg/dl
Median (IQR)
Low
Normal

51.0 (42.0-60.0)
54 (25.4)
159 (74.6)

51.0 (43.0-62.0)
212 (30.6)
482 (69.4)

51.0 (42.0-62.0)
266 (29.3)
641 (70.7)

0.57w
0.15c

Triglyceride, mg/dl
Median (IQR)
High
Normal

86.0 (59.0-135.0)
43 (20.2)
170 (79.8)

94.0 (64.0-141.0)
162 (23.3)
532 (76.7)

94.0 (64.0-143.0)
205 (22.6)
702 (77.4)

0.16w
0.49c

Blood Pressure, mmHg,
Systolic blood pressure
Median (IQR)
< 130
≥ 130
Diastolic blood pressure
Median (IQR)
< 85
≥ 85

0.02c

<0.01c

<0.01 w
<0.01 C

<0.01c

<0.01c

Abbreviations: IQR, interquartile range; ARV, antiretroviral.
c Chi-square statistical test was used to test for association.
w
Wilcoxon rank sum test was used to test for median difference
*p-value highlighted in bold indicate the finding is statistically significant at α=0.05 (p< .05)
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<0.01w
0.54c

Table 1.3 Participants Characteristics stratified by Metabolic Syndrome
Metabolic Syndrome
Yes
No
Demographics
N (%) = 629 (29.2)
N (%) = 1522 (70.8)
Age
Median (IQR)
51.0 (41.0-61.0)
42.0 (30.0-54.0)
20-35
107 (17.0)
543 (35.7)
36-55
271 (43.1)
640 (42.0)
>55
251 (39.9)
339 (22.3)
Gender
Female
332 (52.8)
783 (51.5)
Male
297 (47.2)
739 (48.5)
Race
Hispanic
175 (27.8)
331 (21.8)
White
262 (41.7)
614 (40.3)
African- American
124 (19.7)
314 (20.6)
Other Race/Multi-racial
68 (10.8)
263 (17.3)
Education
≤ High School
307 (48.9)
602 (39.6)
> High School
321 (51.1)
919 (60.4)
Marital Status
Married
365 (58.0)
779 (51.2)
Others
264 (42.0)
743 (48.8)
Poverty to Income Ratio
Median (IQR)
1.9 (1.0-3.6)
2.2 (1.0-4.5)
<1.00
194 (30.8)
446 (29.3)
≥1.00-4.00
310 (49.3)
663 (43.6)
>4.00
125 (19.9)
413 (27.1)
Cigarette Use
Current Smoker
159 (25.3)
341 (22.4)
Past Smoker
158 (25.1)
293 (19.3)
Non-smoker
312 (49.6)
888 (58.3)
Alcohol Use
Current Drinker
Nondrinker

Total
2151
45.0 (33.0-57.0)
650 (30.2)
911 (42.4)
590 (27.4)

Never user

<0.01 w
<0.01c

<0.57
1115 (51.8)
1036 (48.2)
<0.01c
506 (23.5)
876 (40.7)
438 (20.4)
331 (15.4)
<0.01c
909 (42.3)
1240 (57.7)
<0.01c
1144 (53.2)
1007 (46.8)
2.1 (1.0-4.2)
640 (29.8)
970 (45.2)
538 (25.0)

0.01 w
<0.01 C

<0.01c
428 (24.0)
403 (22.5)
956 (53.5)
<0.02c

221 (24.1)

696 (75.9)

917 (100.0)

83 (31.4)

181 (68.6)

264 (100.0)
0.02c

Marijuana Use
Current user

P-value
-

39 (17.7)

181 (82.3)

220 (100)

188 (26.9)

512 (73.1)

700 (100)
0.02c

Concurrent Use
Yes

21 (13.6)

134 (86.4)

155 (100.0)

No

116 (26.4)

324 (73.6)

440 (100.0)

Abbreviations: IQR, interquartile range; ARV, antiretroviral.
c Chi-square statistical test was used to test for association.
w Wilcoxon rank sum test was used to test for median difference
*p-value highlighted in bold indicate the finding is statistically significant at α=0.05 (p< .05)
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Table 2.1: Summary of Stepwise Selection to identify predictors of metabolic syndrome with Alcohol
Use as main independent variable
Effect
Step

Number

Score ChiSq

Pr > ChiSq

DF

In

Alcohol

1

5

2.40

0.12

Age Group

1

1

54.49

<0.01

Race

1

2

9.35

<0.01

Education

1

3

3.93

0.05

Marital status

1

4

2.69

0.10

Cigarette smoking

1

6

2.60

0.16

Entered

Removed

Table 2.2: Summary of Stepwise Selection to identify predictors of metabolic syndrome with
Marijuana Use as main independent variable
Effect
Step

Number

Score ChiSq

Pr > ChiSq

DF

In

Marijuana

1

6

2.87

0.09

Age Group

1

1

35.9

<0.01

Race

1

2

14.10

<0.01

Poverty

1

3

2.52

0.11

Marital status

1

4

2.41

0.12

Cigarette smoking

1

5

1.18

0.28

Entered

Removed

Table 2.3: Summary of Stepwise Selection to identify predictors of metabolic syndrome with
Concurrent Use as main independent variable
Effect
Step

Number

Score ChiSq

Pr > ChiSq

DF

In

Concurrent Use

1

3

2.98

0.08

Age Group

1

1

31.06

<0.01

Race

1

2

8.12

<0.01

Cigarette smoking

1

4

2.21

0.14

Poverty

1

5

1.09

0.30

Entered

Removed
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Table 3.1: Unadjusted Odds ratio for metabolic Syndrome stratified by alcohol, marijuana, and concurrent use

Participant Characteristics

Crude OR (95% CI)

Alcohol Use
Non-drinkera

1.00

Current drinker

0.69 (0.51, 0.94)

Current Drinking Level
Non-drinkera

1.00

Low/Moderate drinker

0.70 (0.49, 0.99)

Heavy drinker

0.82 (0.53, 1.25)

Marijuana Use
Never usera

1.00

Current user

0.59 (0.40, 0.86)

Concurrent Use
Noa

1.00

Yes

0.44 (0.26, 0.73)

Abbreviations: OR, Odds ratio; CI, confidence Interval
a; reference category for alcohol/marijuana/concurrent use/current drinking level
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Table 3.2: Multivariable adjusted OR for metabolic Syndrome stratified by alcohol, marijuana, and concurrent use
Participant Characteristics
Current

drinkera

Adjusted OR (95%)*

(Model 1)

0.69 (0.49, 0.99)

Hispanicb

1.53 (1.06, 2.21)

African American

1.05 (0.72, 1.54)

Other/Multi-racial

0.77 (0.50, 1.20)

Yearsc

2.57 (1.80, 3.68)

36-55

>55 Years
PIR (1.00 –

3.36 (2.26, 4.99)
4.00)d

1.12 (0.79, 1.58)

PIR (> 4.00)

0.88 (0.57, 1.35)

Current smokere

1.20 (0.82, 1.76)

Past smoker

1.72 (1.19, 2.48)

Marriedf

1.26 (0.93, 1.69)

≤High Schoolg
Current marijuana

1.18 (0.87, 1.76)
usera

(Model 2)

0.62 (0.38, 1.01)

Hispanicb

1.11 (0.73, 1.67)

African American

0.82 (0.52, 1.30)

Other/Multi-racial

0.48 (0.29, 0.80)

c

36-55 Years

2.26 (1.55, 3.29)

>55 Years

3.65 (2.06, 6.45)

PIR (1.00 –

4.00)d

0.96 (0.67, 1.38)

PIR (> 4.00)

0.68 (0.41, 1.12)

Current smokere

1.53 (0.97, 2.43)

Past smoker

0.74 (0.42, 1.31)

Marriedf

1.27 (0.90, 1.80)

≤High Schoolg

1.04 (0.73, 1.48)

Concurrent Usea (Model 3)

0.53 (0.28, 0.99)**

b

Hispanic

1.34 (0.79, 2.27)

African American

0.83 (0.47, 1.47)

Other/Multi-racial

0.64 (0.34, 12.0)

36-55 Yearsc

2.95 (1.85, 4.68)

>55 Years

4.00 (1.98, 8.05)

Current smokere

1.50 (0.83, 2.72)

Past Smoker

0.93 (0.45, 1.94)

≤High

Schoolg

1.15 (0.75, 1.77)

Abbreviations: OR, Odds ratio; CI, confidence Interval; PIR, Family Income to Poverty Ratio
*Adjusted model for alcohol and marijuana use included the following covariates: Age, Race, Educational Level, Marital Status,
Poverty, and Cigarette Smoking status.
**Adjusted model included the following covariates: Age, Race, Educational level, Cigarette smoking status.
a; reference category for alcohol/marijuana/concurrent use—nondrinker/never user/non-concurrent user,
b; reference category for race—Whites
c; reference category for age group—age group 20-35 years
d; reference category for family to income ratio—PIR < 1.00
e; reference category cigarette smoking—never smoker
f; reference category for marital status—others
g; reference category for level of education—> High school
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